Re: Cyclosporine A and Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis: A Randomized Comparative Study. J. Sairanen, T. L. J. Tammela, M. Leppilahti, M. Multanen, I. Paananen, K. Lehtoranta and M. Ruutu J Urol, 174: 2235-2238, 2005

Journal of Urology

Volumn 176, Issue 2, 2006, Pages 838-

  Buffington, C A Tony ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; PENTOSAN POLYSULFATE; TACROLIMUS;

ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG MONITORING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL CYSTITIS; KIDNEY FUNCTION; LETTER; LOW DRUG DOSE; PAIN ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CYCLOSPORINE; CYSTITIS, INTERSTITIAL; HUMANS; PENTOSAN SULFURIC POLYESTER; RANDOMIZED CONTROLLED TRIALS;

EID: 33745271346     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.03.044     Document Type: Letter

References (11)

1. Kapturczak M.H., Meier-Kriesche H.U., and Kaplan B. Pharmacology of calcineurin antagonists. Transplant Proc 36 suppl (2004) 25S
2. van de Merwe J.P., Yamada T., and Sakamoto Y. Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders. Int J Urol 10 suppl (2003) S35
3. Groth R.D., Dunbar R.L., and Mermelstein P.G. Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun 311 (2003) 1159
4. Yamamoto Y., and Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107 (2001) 135
5. Bostrom A., Bharath H., Saulewicz A., and Narayanan A.S. Cyclosporin a affects signaling events differentially in human gingival fibroblasts. J Dent Res 84 (2005) 532
6. Homayoun H., Babaie A., Gharib B., Etminani A., Khavandgar S., Mani A., et al. The involvement of nitric oxide in the antinociception induced by cyclosporin A in mice. Pharmacol Biochem Behav 72 (2002) 267
7. Bennett G.J. A neuroimmune interaction in painful peripheral neuropathy. Clin J Pain 16 suppl (2000) S139
8. Kaminska B., Gaweda-Walerych K., and Zawadzka M. Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses. J Cell Mol Med 8 (2004) 45
9. Rezzani R., Corsetti G., Rodella L., and Bianchi R. Cyclosporine-A treatment prevents apoptosis in rat lumbar ganglion cells. Acta Histochem 106 (2004) 129
10. Waldmeier P.C., Zimmermann K., Qian T., Tintelnot-Blomley M., and Lemasters J.J. Cyclophilin D as a drug target. Curr Med Chem 10 (2003) 1485
11. Sairanen J., Forsell T., and Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol 171 (2004) 2138